Featuring perspectives from Dr Heather McArthur, including the following topics:
- Investigator perspectives on recently presented data from clinical trials for HER2-positive localized and metastatic breast cancer (mBC) (0:00)
- Racial and ethnic differences in 21-gene Recurrence Score® and survival among patients with ER-positive breast cancer (28:31)
- Emerging data with CDK4/6 inhibitors for ER-positive, HER2-negative breast cancer (38:22)
- Final overall survival analysis from the TROPiCS-02 study of sacituzumab govitecan for ER-positive, HER2-negative mBC; TROP2 mRNA expression and association with clinical outcomes (1:03:22)
CME information and select publications